10:06 (IST), Dec 24

We want a vaccine which covers a broader kind of the virus. We have had a number of mutations: Former AIIMS director and senior pulmonologist Randeep Guleria on Covid-19 new variant Jn.1

Jn.1 is sub lineage of Omicron. So a vaccine which is made towards Omicron might be efficient towards this variant additionally. We want extra information first to point out what’s the present immunity within the inhabitants, and the safety which have based mostly on the earlier vaccination that we have, based mostly on that, solely can we determine that do we want a brand new vaccine, which covers the present circulating pressure, and that’s one thing that must be accomplished commonly as a result of variants will hold altering, he added.